Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sriharshita Musunuri

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
NPJ Vaccines|January 9, 2024
Bringing immunofocusing into focusSriharshita Musunuri, Payton A B Weidenbacher, Peter S Kim
Biorxiv : the Preprint Server for Biology|May 13, 2026
CBASS limits bacteriophage production while maintaining cell viability in <i>Pseudomonas aeruginosa</i>Erin Huiting, Bruce Wang, Esther Shmidov, et al.
Cell Host & Microbe|June 19, 2026
CBASS limits bacteriophage production while maintaining cell viability in Pseudomonas aeruginosaErin Huiting, Esther Shmidov, Bruce Wang, et al.
Mbio|October 19, 2021
Rapid Proliferation of Pandemic Research: Implications for Dual-Use RisksSriharshita Musunuri, Jonas B Sandbrink, Joshua Teperowski Monrad, et al.
Biochemistry|August 12, 2022
Simplified Purification of Glycoprotein-Modified Ferritin Nanoparticles for Vaccine DevelopmentPayton Weidenbacher, Sriharshita Musunuri, Abigail E Powell, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Intracellular barriers and receptor masking limit success of a <i>Pseudomonas aeruginosa</i> clinical phage familyWearn-Xin Yee, Amy B Banta, Ryan D Ward, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
NPJ Vaccines|January 9, 2024
Bringing immunofocusing into focusSriharshita Musunuri, Payton A B Weidenbacher, Peter S Kim
Biorxiv : the Preprint Server for Biology|May 13, 2026
CBASS limits bacteriophage production while maintaining cell viability in <i>Pseudomonas aeruginosa</i>Erin Huiting, Bruce Wang, Esther Shmidov, et al.
Cell Host & Microbe|June 19, 2026
CBASS limits bacteriophage production while maintaining cell viability in Pseudomonas aeruginosaErin Huiting, Esther Shmidov, Bruce Wang, et al.
Mbio|October 19, 2021
Rapid Proliferation of Pandemic Research: Implications for Dual-Use RisksSriharshita Musunuri, Jonas B Sandbrink, Joshua Teperowski Monrad, et al.
Biochemistry|August 12, 2022
Simplified Purification of Glycoprotein-Modified Ferritin Nanoparticles for Vaccine DevelopmentPayton Weidenbacher, Sriharshita Musunuri, Abigail E Powell, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Intracellular barriers and receptor masking limit success of a <i>Pseudomonas aeruginosa</i> clinical phage familyWearn-Xin Yee, Amy B Banta, Ryan D Ward, et al.
Pageof 1